Related Experiment Video
Updated: Jan 22, 2026

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
Hand-foot Syndrome Secondary to Low-dose Docetaxel in a Breast Cancer Patient
Tariq Kewan1, Mohammad Alomari2, Shrouq Khazaaleh2
1Internal Medicine, Cleveland Clinic - Fairview Hospital, Cleveland, USA.
Abstract:
Docetaxel-induced hand-foot syndrome (HFS) at low doses is a very rare side effect that usually occurs in a dose-dependent manner. HFS can be managed with conservative measures and may need chemotherapy discontinuation. In this report we present a case of HFS in a breast cancer patient after one dose of docetaxel.
Related Concept Videos
Drug Dosing: Geriatric Patients
Drug Dosing: Obese Patients
Muscles of the Leg that Move the Foot and Toes
Anterior Compartment
The anterior compartment includes muscles that contribute to the dorsiflexion of the foot. This compartment houses the tibialis anterior, extensor hallucis longus, and extensor digitorum longus muscles....
Primary and Secondary Growth in Roots and Shoots
Secondary Active Transport
Secondary Healthcare System

